Total Payments
$206,363
2024 Payments
$203,133
Companies
6
Transactions
33
Medicare Patients
5,877
Medicare Billing
$338,961
Payment Breakdown by Category
Consulting$199,556 (96.7%)
Travel$4,039 (2.0%)
Food & Beverage$1,388 (0.7%)
Research$1,380 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $199,556 | 11 | 96.7% |
| Travel and Lodging | $4,039 | 10 | 2.0% |
| Food and Beverage | $1,388 | 11 | 0.7% |
| Unspecified | $1,380 | 1 | 0.7% |
Payments by Type
General
$204,983
32 transactions
Research
$1,380
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $201,245 | 16 | $0 (2024) |
| XVIVO Perfusion Inc. | $2,560 | 7 | $0 (2024) |
| Pulmonx Corporation | $1,336 | 3 | $0 (2019) |
| Spiration, Inc. | $872.19 | 4 | $0 (2018) |
| MEDELA LLC | $316.50 | 2 | $0 (2024) |
| Terumo BCT, Inc. | $33.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203,133 | 18 | United Therapeutics Corporation ($201,084) |
| 2023 | $827.78 | 5 | XVIVO Perfusion Inc. ($827.78) |
| 2022 | $118.35 | 1 | United Therapeutics Corporation ($118.35) |
| 2020 | $33.00 | 1 | Terumo BCT, Inc. ($33.00) |
| 2019 | $362.28 | 3 | Pulmonx Corporation ($319.27) |
| 2018 | $1,220 | 2 | Pulmonx Corporation ($1,016) |
| 2017 | $668.13 | 3 | Spiration, Inc. ($668.13) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $17,565.84 | General |
| Category: Lung Transplant | ||||||
| 11/26/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $16,965.29 | General |
| Category: Lung Transplant | ||||||
| 11/26/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $1,532.72 | General |
| Category: Lung Transplant | ||||||
| 11/14/2024 | XVIVO Perfusion Inc. | XVIVO Perfusion System (XPS) (Device) | Travel and Lodging | In-kind items and services | $1,277.20 | General |
| Category: Transplantation | ||||||
| 11/14/2024 | XVIVO Perfusion Inc. | XVIVO Perfusion System (XPS) (Device) | Food and Beverage | In-kind items and services | $454.90 | General |
| Category: Transplantation | ||||||
| 10/09/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $19,517.60 | General |
| Category: Lung Transplant | ||||||
| 09/27/2024 | United Therapeutics Corporation | Steen Solution (Device) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Lung Transplant | ||||||
| 09/25/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $15,313.81 | General |
| Category: Lung Transplant | ||||||
| 09/25/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $1,571.03 | General |
| Category: Lung Transplant | ||||||
| 08/28/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $14,563.13 | General |
| Category: Lung Transplant | ||||||
| 07/31/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $23,571.25 | General |
| Category: Lung Transplant | ||||||
| 06/12/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $19,667.73 | General |
| Category: Lung Transplant | ||||||
| 05/23/2024 | MEDELA LLC | Dominant Flex (Device) | Food and Beverage | Cash or cash equivalent | $10.12 | General |
| Category: CVS/PTS | ||||||
| 05/22/2024 | United Therapeutics Corporation | — | — | Cash or cash equivalent | $1,380.00 | Research |
| 05/08/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $21,169.08 | General |
| Category: Lung Transplant | ||||||
| 04/28/2024 | MEDELA LLC | Art. 101030215 Thopaz+ Chest Drainage (Device) | Food and Beverage | Cash or cash equivalent | $306.38 | General |
| Category: CT | ||||||
| 04/10/2024 | United Therapeutics Corporation | Steen Solution (Device) | Consulting Fee | Cash or cash equivalent | $48,118.38 | General |
| Category: Lung Transplant | ||||||
| 04/10/2024 | United Therapeutics Corporation | — | Food and Beverage | Cash or cash equivalent | $141.07 | General |
| 03/23/2023 | XVIVO Perfusion Inc. | — | Travel and Lodging | Cash or cash equivalent | $199.00 | General |
| 03/23/2023 | XVIVO Perfusion Inc. | — | Travel and Lodging | Cash or cash equivalent | $15.92 | General |
| 03/23/2023 | XVIVO Perfusion Inc. | — | Travel and Lodging | Cash or cash equivalent | $12.94 | General |
| 03/23/2023 | XVIVO Perfusion Inc. | — | Travel and Lodging | Cash or cash equivalent | $5.97 | General |
| 03/20/2023 | XVIVO Perfusion Inc. | — | Travel and Lodging | Cash or cash equivalent | $593.95 | General |
| 04/27/2022 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $118.35 | General |
| 01/22/2020 | Terumo BCT, Inc. | Spectra Optia Apheresis System (Device) | Food and Beverage | Cash or cash equivalent | $33.00 | General |
| Category: Therapeutic apheresis and cell collection | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 108 | 202 | $424,200 | $35,047 |
| 2022 | 24 | 1,715 | 1,836 | $587,742 | $89,052 |
| 2021 | 26 | 2,665 | 4,815 | $231,837 | $129,737 |
| 2020 | 24 | 1,389 | 2,287 | $145,186 | $85,126 |
Total Patients
5,877
Total Services
9,140
Medicare Billing
$338,961
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 108 | 202 | $424,200 | $35,047 | 8.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 304 | 309 | $96,099 | $13,468 | 14.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 268 | 271 | $85,907 | $11,239 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 89 | $40,050 | $7,957 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 87 | $25,752 | $6,036 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $29,168 | $5,631 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $32,076 | $5,353 | 16.7% |
| J2545 | Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg | Office | 2022 | 38 | 57 | $18,868 | $5,094 | 27.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 226 | 240 | $45,732 | $4,817 | 10.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $25,433 | $4,538 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 27 | $16,308 | $3,524 | 21.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 39 | $17,628 | $3,179 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $17,328 | $2,894 | 16.7% |
| 94070 | Test to measure lung airway sensitivity | Office | 2022 | 61 | 61 | $22,204 | $2,873 | 12.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 97 | 97 | $33,174 | $2,836 | 8.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 28 | 28 | $13,692 | $2,080 | 15.2% |
| 94799 | Other service or procedure on lung | Office | 2022 | 25 | 26 | $10,088 | $1,484 | 14.7% |
| 94642 | Inhalation treatment for pneumonia | Office | 2022 | 41 | 57 | $15,105 | $1,359 | 9.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 23 | $7,222 | $1,315 | 18.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 38 | 44 | $2,174 | $984.36 | 45.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 91 | 91 | $17,745 | $714.14 | 4.0% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 70 | 82 | $7,462 | $643.58 | 8.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $2,366 | $539.12 | 22.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 36 | 36 | $4,788 | $454.81 | 9.5% |
| 94761 | Test to measure oxygen level in blood using ear or finger device multiple times | Office | 2022 | 14 | 14 | $1,372 | $38.30 | 2.8% |
About Dr. Jorge Mallea, MD
Dr. Jorge Mallea, MD is a Pulmonary Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306825781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Mallea, MD has received a total of $206,363 in payments from pharmaceutical and medical device companies, with $203,133 received in 2024. These payments were reported across 33 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($199,556).
As a Medicare-enrolled provider, Mallea has provided services to 5,877 Medicare beneficiaries, totaling 9,140 services with total Medicare billing of $338,961. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Jacksonville, FL
- Active Since 01/12/2006
- Last Updated 09/02/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1306825781
Products in Payments
- Steen Solution (Device) $199,563
- XVIVO Perfusion System (XPS) (Device) $1,732
- Pulmonx Endobronchial Valve EBV (Device) $1,336
- Spiration Valve System (Device) $872.19
- Art. 101030215 Thopaz+ Chest Drainage (Device) $306.38
- ORENITRAM (Drug) $43.01
- Spectra Optia Apheresis System (Device) $33.00
- Dominant Flex (Device) $10.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Jacksonville
Dr. Abubakr Bajwa, M.d, M.D
Pulmonary Disease — Payments: $586,209
Pulmonary Disease $586,209
Charles Burger, Md, MD
Pulmonary Disease — Payments: $141,922
Pulmonary Disease $141,922
Dr. Sebastian Fernandez-Bussy, M.d, M.D
Pulmonary Disease — Payments: $125,148
Pulmonary Disease $125,148
Dr. Daniel Wyzan, Md, MD
Pulmonary Disease — Payments: $113,878
Pulmonary Disease $113,878
Peter Nassar, Md, MD
Pulmonary Disease — Payments: $80,367
Pulmonary Disease $80,367
Mitchell Rothstein, Md, MD
Pulmonary Disease — Payments: $64,712
Pulmonary Disease $64,712